OMNIPRISM GOES BEYOND THE SCOPE

OMNIPATHOLOGY IS A PROBLEM-SOLVING PARTNER DEDICATED TO HELPING YOU PROVIDE BETTER CARE BY INCORPORATING ADVANCED TECHNOLOGIES INTO ROUTINE TESTING. OUR COMPREHENSIVE APPROACH FACILITATES BETTER FOLLOW-UP DECISIONS AND ENHANCES EARLY CANCER DETECTION – DESIGNED TO ANSWER THE DIFFICULT QUESTIONS.

C-MYC FISH HELPS PREDICT HIGH RISK CIN1 LESIONS:

- Over-treatment of CIN1 lesions can have negative impact on young women and potential adverse pregnancy outcomes.
- CIN1 Patients with high c-MYC copy numbers show significantly increased risk of persistent and progressive dysplasia*
- This allows treatment to be based on the biological and behavioral diversity of the lesions.

TERC FISH DETECTS CYTOGENITIC ABNORMALITIES BEFORE MORPHOLOGICAL CHANGES:

- TERC FISH assay is performed on cervical and anal pap smears. Through comparison of TERC and 3p telomere fluorescent signals, the test is designed to help differentiate between normal/low-grade dysplasia and high-grade dysplasia/carcinoma.
- 3q26 (TERC) detected gains in 80% of cervical intraepithelial neoplasia grade 2-3 (CIN2-3) cases and in 100% of squamous cell carcinoma (SCC) cases.
- TERC FISH complements cytomorphological assessment.